According to Gram Research analysis, a heart disease risk score called SCORE2 can help identify middle-aged women with early memory and thinking problems. In a study of 89 women, those with high cardiovascular risk were 6.2 times more likely to have cognitive impairment, with rates rising from 21% in low-risk women to 62.5% in high-risk women. Women with high blood pressure showed cognitive impairment at nearly five times the rate of those with normal blood pressure. Doctors could use SCORE2, already calculated routinely in primary care, as a simple screening signal to identify women who need formal memory testing, at no additional cost.
Researchers discovered that a heart disease risk score called SCORE2, already used in doctor’s offices, can help identify women with early memory and thinking problems. In this study of 89 women aged 40-68, those with higher heart disease risk were much more likely to have cognitive impairment. Women with high blood pressure had five times more memory problems than those with normal blood pressure. The findings suggest doctors could use existing heart health measurements to spot thinking problems early, potentially leading to earlier treatment and better outcomes for midlife women.
Key Statistics
A 2026 single-center feasibility study of 89 women found that SCORE2 cardiovascular risk scores showed a clear dose-response association with cognitive impairment, with prevalence rising from 21.2% in low-risk women to 62.5% in high-risk women (p = 0.006).
Women with high blood pressure had cognitive impairment at a rate of 53.8% compared to 10.8% in normotensive controls, a relative risk of 4.98, according to the 2026 study published in Frontiers in Medicine.
A machine learning model using five variables (age, BMI, systolic blood pressure, hypertension duration, and folate) achieved 80.4% accuracy in identifying cognitive impairment in the 89-woman study, only modestly better than SCORE2 alone at 74.2%.
The 2026 feasibility study found that cognitive impairment prevalence rose monotonically from 7.7% in women with zero cardiometabolic risk factors to 66.7% in those with four risk factors (p ≤ 0.002).
The Quick Take
- What they studied: Can a heart disease risk calculator help doctors spot early memory and thinking problems in middle-aged women?
- Who participated: 89 women between ages 40-68, including 52 with high blood pressure and 37 with normal blood pressure, from a single medical center
- Key finding: Women with high cardiovascular risk scores were 6 times more likely to have memory problems; overall, 36% of women studied showed signs of cognitive impairment, with hypertensive women affected at nearly 5 times the rate of controls
- What it means for you: If you’re a middle-aged woman with high blood pressure or other heart disease risk factors, asking your doctor about a simple memory screening could catch thinking problems early. This is a promising first step, but more research in larger groups is needed before this becomes standard practice.
The Research Details
This was a single-center feasibility study, meaning researchers tested whether an idea could work in one medical practice before rolling it out more widely. They enrolled 89 women and measured their heart disease risk using SCORE2, a scoring system doctors already use routinely. The researchers then gave all participants a standard memory test called the Mini-Mental State Examination (MMSE) to check for thinking problems. They looked for patterns: did women with higher heart disease risk scores also have more memory problems? The study also used artificial intelligence to build a simpler prediction tool using five easy-to-measure factors: age, weight, blood pressure, how long someone had high blood pressure, and folate levels.
This approach is efficient because it uses information doctors already collect. Rather than adding new tests or costs to doctor visits, the study shows that existing heart disease risk calculations might double as an early warning system for memory problems. This ’two-for-one’ approach could help catch cognitive impairment early in women, when treatment might be most effective.
The study was small (89 women) and conducted in only one medical center, which limits how much we can generalize the findings. However, the researchers used rigorous statistical methods and followed international reporting standards for AI-assisted research. The study was designed as a feasibility test, not a definitive answer, the authors explicitly call for larger, multi-center studies before this approach is used in routine clinical practice. The findings are promising but preliminary.
What the Results Show
The SCORE2 heart disease risk score showed a clear dose-response relationship with memory problems: as cardiovascular risk increased, so did cognitive impairment rates. In the low-risk group, 21.2% had memory problems; in the moderate-risk group, 50%; in the high-risk group, 62.5%; and in the very-high-risk group, 60%. This pattern was statistically significant (p = 0.006), meaning it’s unlikely to be due to chance. Women with high cardiovascular risk were 6.21 times more likely to have cognitive impairment compared to low-risk women. The SCORE2 score alone could identify memory problems with 74.2% accuracy, which is reasonably good for a screening tool. The most striking finding was the difference between women with and without high blood pressure: 53.8% of hypertensive women showed cognitive impairment versus only 10.8% of those with normal blood pressure, a nearly five-fold difference.
The researchers found that cognitive impairment increased consistently across multiple cardiometabolic risk factors. Women progressed from normal blood pressure to Stage 2 hypertension showed memory problem rates rising from 11.1% to 60.6%. Similarly, as BMI increased from normal to obese, cognitive impairment rose from 13.8% to 59%. When researchers combined multiple risk factors into a cumulative score, the effect was even stronger: women with zero risk factors had 7.7% cognitive impairment, while those with four risk factors had 66.7%. A machine learning model using five simple variables (age, BMI, systolic blood pressure, hypertension duration, and folate) performed slightly better than SCORE2 alone, with 80.4% accuracy, but the improvement was modest.
This research builds on growing evidence that cardiovascular health and brain health are connected. Previous studies have shown that high blood pressure, obesity, and poor heart health are linked to memory problems and dementia risk. This study is novel because it tests whether an existing, widely-used heart disease risk tool can serve double duty as a cognitive screening signal. The findings align with prior research showing that midlife women are at particular risk for undetected cognitive problems, yet this population is often overlooked in primary care settings.
The study was small (89 women) and conducted in a single medical center, so results may not apply to all women or different populations. The study was cross-sectional, meaning it captured a snapshot in time rather than following women over years, so we can’t prove that high heart disease risk actually causes memory problems, only that they occur together. The memory test used (MMSE ≤23) is a screening tool, not a diagnostic test, so some women identified as having ‘cognitive impairment’ might not have a true clinical condition. The study lacked diversity in some respects and used a Turkish-specific cutoff score for the memory test. Most importantly, the authors emphasize this is a feasibility study requiring external validation in larger, diverse populations before clinical use.
The Bottom Line
For women aged 40 and above, especially those with high blood pressure, obesity, or other heart disease risk factors: discuss cognitive screening with your primary care doctor. The SCORE2 cardiovascular risk score your doctor may already calculate could serve as a reminder to check your thinking and memory. If you have multiple cardiometabolic risk factors, ask specifically about memory screening. For healthcare providers: consider using SCORE2 as a triage signal to identify women who might benefit from formal cognitive testing, at no additional cost. However, await larger validation studies before implementing this as standard practice. Confidence level: Moderate, promising preliminary evidence, but single-center feasibility study requires multi-center validation.
This research is most relevant to: middle-aged women (40-68) with high blood pressure, obesity, or other cardiovascular risk factors; primary care doctors and family medicine practitioners; women’s health specialists; and public health officials interested in early detection of cognitive impairment. Women with normal blood pressure and no cardiometabolic risk factors have lower cognitive impairment rates in this study, though screening may still be appropriate based on individual circumstances. Men were not studied, so applicability to male populations is unknown.
This is a screening and early detection study, not a treatment study, so there’s no ’timeline to benefit’ in the traditional sense. If cognitive impairment is detected early through SCORE2-guided screening, earlier intervention might slow progression, but that requires further research. The practical timeline is immediate: women can discuss cognitive screening with their doctors now, using existing heart disease risk assessments as a conversation starter.
Frequently Asked Questions
Can a heart disease risk score help doctors find memory problems in middle-aged women?
Yes, research shows SCORE2 cardiovascular risk scores correlate with cognitive impairment in women aged 40-68. Women with high cardiovascular risk had 6.2 times higher rates of memory problems. Doctors could use this existing calculation as a screening signal without additional tests.
What is the connection between high blood pressure and memory problems in women?
This study found women with high blood pressure had cognitive impairment at 53.8% compared to 10.8% in those with normal blood pressure. The mechanism isn’t fully understood, but high blood pressure may damage blood vessels in the brain, affecting thinking and memory function.
Should I get a memory test if I have high cardiovascular risk?
If you’re a middle-aged woman with high blood pressure, obesity, or other heart disease risk factors, discussing cognitive screening with your doctor is reasonable. This preliminary research suggests it could identify early problems, though larger studies are needed before this becomes standard practice.
How accurate is SCORE2 at detecting cognitive impairment?
SCORE2 identified cognitive impairment with 74.2% accuracy in this 89-woman study. While reasonably good for a screening tool, it’s not perfect, some women with high scores won’t have memory problems, and some with low scores might. It works best as a triage signal, not a definitive diagnosis.
What factors besides blood pressure increase cognitive impairment risk in women?
This study found obesity, long-standing hypertension, and low folate levels also correlated with memory problems. The effect was cumulative: women with multiple risk factors (high blood pressure, obesity, elevated BMI) had much higher cognitive impairment rates than those with single risk factors.
Want to Apply This Research?
- Track your SCORE2 cardiovascular risk score (if your doctor has calculated it) alongside quarterly self-administered memory checks using validated tools like the Montreal Cognitive Assessment (MoCA) or simple word-recall tests. Log your systolic blood pressure, BMI, and any cognitive symptoms (difficulty remembering names, misplacing items, trouble concentrating) to identify patterns over time.
- If your app shows you have moderate-to-high cardiovascular risk based on SCORE2 components (high blood pressure, elevated BMI, or long-standing hypertension), set a reminder to schedule a formal cognitive screening with your doctor. Use the app to track blood pressure management, weight loss progress, and medication adherence, all factors that may influence both heart and brain health.
- Establish a baseline cognitive assessment with your healthcare provider, then use the app to monitor cardiovascular risk factors monthly (blood pressure, weight, BMI). Set annual reminders for formal cognitive testing if you have moderate-to-high cardiovascular risk. Track lifestyle factors (exercise, diet quality, folate intake, sleep) that influence both cardiovascular and cognitive health. Share trends with your doctor to guide preventive interventions.
This research is a single-center feasibility study and should not be used as a basis for clinical diagnosis or treatment decisions without consultation with a qualified healthcare provider. The findings are preliminary and require external validation in larger, diverse populations before clinical implementation. Memory problems identified by screening tools like MMSE are not diagnostic of dementia or cognitive disorders, formal neuropsychological evaluation is needed for diagnosis. Women should discuss cognitive concerns and screening options with their primary care doctor or neurologist. This article is for educational purposes only and does not replace professional medical advice. If you experience memory problems, confusion, or cognitive changes, seek evaluation from a qualified healthcare provider immediately.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
